SOLUBLE GUANYLATE CYCLASE ACTIVATORS

A compound of Formula (I): or a pharmaceutically acceptable salt thereof, are capable of modulating the body's production of cyclic guanosine monophosphate ("cGMP") and are generally suitable for the therapy and prophylaxis of diseases which are associated with a disturbed cGMP balanc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: WADDELL, SHERMAN, T, MIAO, SHOUWU, CHANG, JIANG, ROSAUER, KEITH, GROEPER, JONATHAN, A, LI, HONG, CHEN, YI-HENG, WHITEHEAD, ALAN, HAN, XIAOQING, LIAO, XIBIN, SMITH, CAMERON, J, STELMACH, JOHN, E, PARMEE, EMMA, R, GARFUNKLE, JOIE, BROCKUNIER, LINDA, L, ORNOSKI, OLGA, A, RAGHAVAN, SUBHAREKHA, GUO, JIAN
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A compound of Formula (I): or a pharmaceutically acceptable salt thereof, are capable of modulating the body's production of cyclic guanosine monophosphate ("cGMP") and are generally suitable for the therapy and prophylaxis of diseases which are associated with a disturbed cGMP balance. The invention furthermore relates to processes for preparing compounds of Formula I, or a pharmaceutically acceptable salt thereof, for their use in the therapy and prophylaxis of the abovementioned diseases and for preparing pharmaceuticals for this purpose, and to pharmaceutical preparations which comprise compounds of Formula (I) or a pharmaceutically acceptable salt thereof.